Huvepharma EOOD Sustainability Profile
Huvepharma EOOD, a prominent player in the pharmaceutical industry, is headquartered in Bulgaria (BG) and operates extensively across Europe, North America, and Asia. Founded in 2001, the company has established itself as a leader in the development and production of veterinary pharmaceuticals, with a strong focus on animal health and nutrition. Huvepharma's core offerings include a diverse range of products such as antibiotics, vaccines, and nutritional supplements, all designed to enhance animal welfare and productivity. What sets Huvepharma apart is its commitment to innovation and quality, ensuring that its products meet the highest industry standards. With a robust market position, the company has achieved significant milestones, including numerous regulatory approvals and partnerships that underscore its reputation in the global market.
DitchCarbon Score
How does Huvepharma EOOD's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Huvepharma EOOD's score of 14 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Huvepharma EOOD's reported carbon emissions
Huvepharma EOOD, headquartered in Bulgaria (BG), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a current subsidiary, Huvepharma EOOD's climate commitments and emissions data may be influenced by its corporate family, but specific details regarding cascading from a parent organization are not available. The company has not established any Science-Based Targets Initiative (SBTi) reduction targets or other industry-standard climate initiatives at this time. In the context of the pharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction strategies. However, without specific emissions data or commitments, Huvepharma EOOD's current climate impact remains unclear.
How Carbon Intensive is Huvepharma EOOD's Industry?
How Carbon Intensive is Huvepharma EOOD's Location?
Huvepharma EOOD's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Huvepharma EOOD has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
